Microsoft settles antitrust suits: resolution of state cases helps software firm put bulk of issues behind it
Article Abstract:
Consumer class-action antitrust suits have been settled by Microsoft Corp. Under the settlements, Microsoft will pay for consumer vouchers for purchasing computer software and equipment, and are valued up to approximately $200 million.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
Prepackaged software, Legal issues & crime, Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors, Antitrust Law, Legal/Government Regulation, Computer software industry, Software industry, Company legal issue, Cases, Microsoft Corp., MSFT, Antitrust issue
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Kodak cuts dividend to finance digital shift
Article Abstract:
Eastman Kodak Co. has reduced its dividend from $1.80 to .50 cents. The company has been hurt by falling profits and sales in its main film business.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
Financial management, Photographic studios, portrait, Photographic Services, Photography Studios, Portrait, Dividends, Dividend Policy, Finance, Securities, Photographic industry, Eastman Kodak Co., EK, Company financing, Company dividends
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States
Similar abstracts:
- Abstracts: EU's Microsoft move could set precedent. Competitive landscape to change if software firm is forced to ditch bundling
- Abstracts: EU sets antitrust charges on Visa, renewing its scrutiny of industry. AstraZeneca faces EU antitrust claims
- Abstracts: Novartis offers to buy rest of Chiron. Novartis agrees to acquire the rest of Chiron for $5.1 billion. Biotech industry heads toward IPO boomlet
- Abstracts: Shiites threaten to create a second U.S. front in Iraq: uprising of Sadr militants is also awakening doubts about June power transfer
- Abstracts: Airbus sees an opening in U.S. military market. Airbus firms up plans for a new jet
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.